EFFICACY AND SAFETY FROM A PHASE 2B TRIAL OF SM04690, A NOVEL, INTRA-ARTICULAR, WNT PATHWAY INHIBITOR FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE

被引：9
|
作者：
Yazici, Y. [1 ]
McAlindon, T. E. [2 ]
Gibofsky, A. [3 ,4 ]
Lane, N. E. [5 ]
Latterman, C. [6 ]
Skrepnik, N. [7 ]
Swearingen, C. J. [1 ]
DiFrancesco, A. [1 ]
Tambiah, J. R. [1 ]
Hochberg, M. C. [8 ]
机构：
[1] Samumed, San Diego, CA USA
[2] Tufts Med Ctr, Boston, MA 02111 USA
[3] Weill Cornell Med Coll, New York, NY USA
[4] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA
[5] Univ Calif Davis, Med Ctr, Davis, CA USA
[6] Harvard Univ, Brigham & Womens Hosp, Cambridge, MA 02138 USA
[7] Tucson Orthoped Inst, Tucson, AZ USA
[8] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
来源：
OSTEOARTHRITIS AND CARTILAGE | 2019年 / 27卷
关键词：
D O I：
10.1016/j.joca.2019.02.566
中图分类号：
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];
学科分类号：
摘要：
728
引用
收藏
页码：S503 / S503
页数：1
相关论文
共 50 条
  • [21] INTEGRATED SAFETY SUMMARY OF THE NOVEL, INTRA-ARTICULAR AGENT LORECIVIVINT (LOR; SM04690), A CLK/DYRK1A INHIBITOR THAT MODULATES THE WNT PATHWAY, IN SUBJECTS WITH KNEE OSTEOARTHRITIS
    Simsek, I.
    Swearingen, C.
    Kennedy, S.
    Tambiah, J.
    Damatarca, C.
    Yazici, Y.
    Lane, N.
    Hochberg, M.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S606 - S607
  • [22] Radiographic Outcomes from a Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of a Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee
    Swearingen, Christopher J.
    Majumdar, Sharmila
    Simsek, Ismail
    DiFrancesco, Anita
    Tambiah, Jeymi
    Yazici, Yusuf
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [23] Intra-articular injection of a novel Wnt pathway inhibitor, SM04690, upregulates Wnt16 expression and reduces disease progression in temporomandibular joint osteoarthritis
    Hua, Bingqiang
    Qiu, Jin
    Ye, Xiaoping
    Liu, Xianwen
    BONE, 2022, 158
  • [24] Safety, Efficacy and Biomarker Outcomes of a Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in the Treatment of Osteoarthritis of the Knee: Interim, Exploratory Analysis of Results from a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study
    Yazici, Yusuf
    McAlindon, Timothy E.
    Fleischmann, Roy
    Gibofsky, Allan
    Lane, Nancy E.
    Kivitz, Alan J.
    Skrepnik, Nebojsa
    Armas, Eddie
    Swearingen, Christopher J.
    DiFrancesco, Anita
    Tambiah, Jeyanesh R. S.
    Hood, John
    Hochberg, Marc C.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [25] RADIOGRAPHIC OUTCOMES FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF A NOVEL, INTRA-ARTICULAR, INJECTABLE, WNT PATHWAY INHIBITOR (SM04690) IN THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE: WEEK 26 INTERIM ANALYSIS
    Yazici, Y.
    McAlindon, T. E.
    Gibofsky, A.
    Lane, N. E.
    Skrepnik, N.
    Armas, E.
    Swearingen, C. J.
    DiFrancesco, A.
    Tambiah, J. R.
    Hochberg, M. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 121 - 121
  • [26] CLINICAL OUTCOMES FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY OF A NOVEL, INTRA-ARTICULAR, INJECTABLE, WNT PATHWAY INHIBITOR (SM04690) FOR THE TREATMENT OF KNEE OSTEOARTHRITIS: WEEK 26 INTERIM ANALYSIS
    Yazici, Y.
    Gibofsky, A.
    Lane, N. E.
    Skrepnik, N.
    Armas, E.
    Swearingen, C. J.
    DiFrancesco, A.
    Tambiah, J. R.
    McAlindon, T. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 985 - 986
  • [27] DISCOVERY OF A SMALL MOLECULE INHIBITOR OF THE WNT PATHWAY (SM04690) AS A POTENTIAL DISEASE MODIFYING TREATMENT FOR KNEE OSTEOARTHRITIS
    Hood, J. D.
    Deshmukh, V.
    Barroga, C.
    Hu, Y.
    OSTEOARTHRITIS AND CARTILAGE, 2016, 24 : S14 - S15
  • [28] DISCOVERY OF A SMALL MOLECULE INHIBITOR OF THE WNT PATHWAY (SM04690) AS A POTENTIAL DISEASE MODIFYING TREATMENT FOR KNEE OSTEOARTHRITIS
    Hood, J.
    Barroga, C.
    Hu, Y.
    Deshmukh, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 81 - 81
  • [29] DISCOVERY OF A SMALL MOLECULE WNT PATHWAY INHIBITOR (SM04690) AS A POTENTIAL DISEASE MODIFYING TREATMENT FOR KNEE OSTEOARTHRITIS
    Lane, N. E.
    Deshmukh, V.
    Barroga, C.
    Hu, H.
    Kc, S.
    Yazici, Y.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S56 - S57
  • [30] A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis
    Yazici, Y.
    McAlindon, T. E.
    Gibofsky, A.
    Lane, N. E.
    Lattermann, C.
    Skrepnik, N.
    Swearingen, C. J.
    Simsek, I.
    Ghandehari, H.
    DiFrancesco, A.
    Gibbs, J.
    Tambiah, J. R. S.
    Hochberg, M. C.
    OSTEOARTHRITIS AND CARTILAGE, 2021, 29 (05) : 654 - 666
12345